DaVita Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by DaVita Inc. on October 23, 2008. The filing addresses significant changes in executive leadership, specifically the departure of the Chief Operating Officer and the appointment of a successor.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and personnel changes rather than financial performance.
Material Changes
- Departure of Chief Operating Officer: Joseph C. Mello will retire as Chief Operating Officer effective December 31, 2008.
- Transition Period: Mr. Mello will remain with the company on a full-time basis through May 2009 and on a part-time basis thereafter.
- Appointment of New Chief Operating Officer: Dennis Kogod, currently the Company's President-West, will assume the role of Chief Operating Officer effective January 1, 2009.
- Successor Background: Mr. Kogod has served as President-West since October 2005. Prior to joining DaVita, he held executive roles at Gambro Healthcare, Inc. (acquired by DaVita in 2005) and Teleflex Medical Group.
Guidance, Outlook, and Risks
The filing does not contain financial guidance, outlook, or specific risk factors related to operations. It notes that there are no family relationships between Mr. Kogod and other directors or officers, and no material transactions involving Mr. Kogod or his immediate family have occurred since the beginning of the last fiscal year.
Investor Verification Checklist
- Verify the effective dates of the leadership transition (Dec 31, 2008 for retirement; Jan 1, 2009 for appointment).
- Review the attached Press Release (Exhibit 99.1) for additional context on the retirement.
- Confirm the terms of Mr. Kogod's employment agreement (Exhibit 10.1), which was originally filed in November 2005.
- Monitor subsequent filings for any financial impact related to the executive transition.